RHYTHM PHARMACEUTICALS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

RHYTHM PHARMACEUTICALS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $189.76 million for the year ending 2025.

  • RHYTHM PHARMACEUTICALS, INC. showed an increase of +45.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from RHYTHM PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), RHYTHM PHARMACEUTICALS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 702.8%.
  • Historical annual values: Fiscal year 2025: $189.76 million | Fiscal year 2024: $130.13 million | Fiscal year 2023: $77.43 million | Fiscal year 2022: $23.64 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: